# A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

> **NCT02400775** · PHASE4 · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Essential Hypertension With Stable Angina and Dyslipidemia

## Interventions

- **DRUG:** Azilsartan

## Key facts

- **NCT ID:** NCT02400775
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02400775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02400775, "A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02400775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*